Inspire Medical Systems Faces Class Action Lawsuit Over Alleged Securities Fraud

Reuters12-12

<a href="https://laohu8.com/S/INSP">Inspire Medical Systems</a> Faces Class Action Lawsuit Over Alleged Securities Fraud

A class action lawsuit has been filed against Inspire Medical Systems Inc. on behalf of investors who suffered losses between August 6, 2024, and August 4, 2025, due to alleged securities fraud. The complaint alleges that the company and its executives misled investors about the launch of its new product, Inspire V, claiming a successful rollout while concealing significant operational failures. According to the lawsuit, demand for Inspire V was poor, with providers holding surplus inventory and hesitating to transition to the new treatment. Additionally, Inspire Medical Systems reportedly failed to complete essential tasks for the launch, including training and onboarding for many treatment centers, setting up basic IT systems, ensuring insurer claims software was updated, and securing Medicare reimbursement. These issues ultimately contradicted the company's public assurances about the product's launch and performance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Medical Systems Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1117003) on December 12, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590725506?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-12 20:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590725506","market":"us","top_or_hot":-1,"title":"Inspire Medical Systems Faces Class Action Lawsuit Over Alleged Securities Fraud","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/INSP\">Inspire Medical Systems</a> Faces Class Action Lawsuit Over Alleged Securities Fraud\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        A class action lawsuit has been filed against Inspire Medical Systems Inc. on behalf of investors who suffered losses between August 6, 2024, and August 4, 2025, due to alleged securities fraud. The complaint alleges that the company and its executives misled investors about the launch of its new product, Inspire V, claiming a successful rollout while concealing significant operational failures. According to the lawsuit, demand for Inspire V was poor, with providers holding surplus inventory and hesitating to transition to the new treatment. Additionally, Inspire Medical Systems reportedly failed to complete essential tasks for the launch, including training and onboarding for many treatment centers, setting up basic IT systems, ensuring insurer claims software was updated, and securing Medicare reimbursement. These issues ultimately contradicted the company's public assurances about the product's launch and performance.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Medical Systems Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1117003) on December 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inspire Medical Systems Faces Class Action Lawsuit Over Alleged Securities Fraud</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInspire Medical Systems Faces Class Action Lawsuit Over Alleged Securities Fraud\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-12 20:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/INSP\">Inspire Medical Systems</a> Faces Class Action Lawsuit Over Alleged Securities Fraud\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        A class action lawsuit has been filed against Inspire Medical Systems Inc. on behalf of investors who suffered losses between August 6, 2024, and August 4, 2025, due to alleged securities fraud. The complaint alleges that the company and its executives misled investors about the launch of its new product, Inspire V, claiming a successful rollout while concealing significant operational failures. According to the lawsuit, demand for Inspire V was poor, with providers holding surplus inventory and hesitating to transition to the new treatment. Additionally, Inspire Medical Systems reportedly failed to complete essential tasks for the launch, including training and onboarding for many treatment centers, setting up basic IT systems, ensuring insurer claims software was updated, and securing Medicare reimbursement. These issues ultimately contradicted the company's public assurances about the product's launch and performance.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Medical Systems Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1117003) on December 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL50yPBr:1","article_id":"2590725506","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590725506","pubTimestamp":1765543950,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"A class action lawsuit has been filed against Inspire Medical Systems Inc. on behalf of investors who suffered losses between August 6, 2024, and August 4, 2025, due to alleged securities fraud. The complaint alleges that the company and its executives misled investors about the launch of its new product, Inspire V, claiming a successful rollout while concealing significant operational failures. According to the lawsuit, demand for Inspire V was poor, with providers holding surplus inventory and hesitating to transition to the new treatment. Additionally, Inspire Medical Systems reportedly failed to complete essential tasks for the launch, including training and onboarding for many treatment centers, setting up basic IT systems, ensuring insurer claims software was updated, and securing Medicare reimbursement. These issues ultimately contradicted the company's public assurances about the product's launch and performance.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","BK4167":"医疗保健技术","LU2065731478.USD":"ALLSPRING (LUX) WORLDWIDE FUND - SMALL CAP INNOVA \"I\" (USD) ACC","INSP":"Inspire Medical Systems"},"translate_title":"Inspire Medical Systems因涉嫌证券欺诈面临集体诉讼","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INSP":0.9},"content_text":"Inspire Medical Systems Faces Class Action Lawsuit Over Alleged Securities Fraud\n    \n\n        A class action lawsuit has been filed against Inspire Medical Systems Inc. on behalf of investors who suffered losses between August 6, 2024, and August 4, 2025, due to alleged securities fraud. The complaint alleges that the company and its executives misled investors about the launch of its new product, Inspire V, claiming a successful rollout while concealing significant operational failures. According to the lawsuit, demand for Inspire V was poor, with providers holding surplus inventory and hesitating to transition to the new treatment. Additionally, Inspire Medical Systems reportedly failed to complete essential tasks for the launch, including training and onboarding for many treatment centers, setting up basic IT systems, ensuring insurer claims software was updated, and securing Medicare reimbursement. These issues ultimately contradicted the company's public assurances about the product's launch and performance.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Medical Systems Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1117003) on December 12, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory,event","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590725506","isCrawlerRequest":true}